Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Peregrine Pharmaceuticals begins phase III trial of bavituximab

Jan. 2, 2014

OncoTherapy Science stops phase III study of C-01 for pancreatic cancer

Dec. 27, 2013

NewLink Genetics begins phase I trial of HyperAcute Renal

Dec. 27, 2013

Cancer vaccine K562/GM-CSF evaluated in patients with myelodysplastic syndrome

Dec. 27, 2013

Cervarix two-dose schedule receives European marketing authorization

Dec. 24, 2013

Regulatory application filed for nivolumab in malignant melanoma

Dec. 24, 2013

California Stem Cell completes phase I stem cell trial for HCC

Dec. 23, 2013

Roche to study RO-6895882 in advanced and/or metastatic solid tumors

Dec. 23, 2013

GSK and Genmab receive FDA priority review for Arzerra BLA

Dec. 19, 2013

Chimeric antigen receptor therapy for pediatric ALL targets the TSLPR

Dec. 18, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...